ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

RZLT Rezolute Inc

3.31
0.34 (11.45%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Rezolute Inc RZLT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.34 11.45% 3.31 07:53:39
개장가 저가 고가 종가 전일 종가
3.06 2.98 3.38 3.31 2.97
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/04/202421:00GLOBEPhase 2 RIZE Study Sub-Analyses to be Presented at the 2024..
12/03/202406:03EDGAR2Form 8-K - Current report
11/03/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202421:30GLOBERezolute Reports Validation of the Potential Use of RZ358..
27/02/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202407:00EDGAR2Form 8-K - Current report
22/02/202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202407:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202406:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/02/202406:10EDGAR2Form 8-K - Current report
14/02/202406:05GLOBERezolute Reports Second Quarter Fiscal 2024 Results and..
30/01/202407:15EDGAR2Form 8-K - Current report
26/01/202402:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202422:00GLOBERezolute Expands Leadership Team with Appointment of Daron..
23/01/202422:00GLOBERezolute Receives Innovation Passport Designation from the..
15/12/202306:01EDGAR2Form 8-K - Current report
14/12/202322:00GLOBERezolute Initiates Phase 3 Clinical Study for RZ358 in..
13/12/202322:00GLOBERezolute Completes Enrollment of its Phase 2 Study in..
30/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
23/11/202307:16EDGAR2Form S-3/A - Registration statement under Securities Act of..
23/11/202306:35EDGAR2Form 8-K - Current report
17/11/202322:00GLOBERezolute to Participate in BTIG’s 3rd Annual Ophthalmology..
15/11/202323:08EDGAR2Form S-3 - Registration statement under Securities Act of..
14/11/202306:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:13EDGAR2Form 8-K - Current report
14/11/202306:05GLOBERezolute Reports First Quarter Fiscal 2024 Results
19/10/202305:30EDGAR2Form 8-K - Current report
17/10/202321:00GLOBERezolute Receives Priority Medicines (PRIME) Eligibility..
14/10/202305:47EDGAR2Form 8-K - Current report
14/10/202305:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/10/202321:00GLOBERezolute Announces Further Evidence of RZ358’s Efficacy in..
15/09/202305:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/09/202305:10EDGAR2Form 8-K - Current report
15/09/202305:05GLOBERezolute Reports Full Year Fiscal 2023 Results and..
06/09/202320:00GLOBERezolute to Participate in Upcoming Investor Conferences in..
07/07/202300:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/06/202305:05GLOBERezolute to Initiate a Pivotal Phase 3 Study of RZ358 in..
12/05/202305:05GLOBERezolute Reports Third Quarter Fiscal 2023 Results and..

최근 히스토리

Delayed Upgrade Clock